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positively on prescribing behavior at Ussher Polyclinic with significant changes 
between the pre-intervention and post-intervention periods.  
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OBJECTIVES: The Pharmacy and Therapeutic Committee in the hospital planned 
to study the aggregate medicine use in the hospital. After implementation of the 
Essential Drug List (EDL) 2011, it was important to know the consumption and 
cost contributed by each pharmaceuticals in the list so that further revisions 
could be done on the list annually. METHODS: The study was conducted for one 
year using Always Better Control (ABC) analysis of pharmaceuticals in the EDL. 
Pharmaceuticals from the EDL were categorized for A (70%) B (20%) C (10%) 
categories. The calculations were done from a period of January 11, 2011 to 
January 11, 2012 using the data from the hospital billing database. RESULTS: The 
total annual drug expenditure (ADE) was Rs. 2,61,78,251. Out of 311 
pharmaceuticals in the list, 47 (15%) were in A group, 60 (19%) were in B group 
and the remaining 204 (66%) were in C group. In the A group 45% of the 
pharmaceuticals were belong to ATC category J (Antimicrobials). Out of the top 
10 pharmaceuticals, the costlier one was Anti D Immunoglobulin costing Rs. 
1995. But it came on sixth position as the consumption was lesser than the other 
ones in the top. The first one was Lopinavir-Ritonavir combination with an 
annual cost of 13, 76529. Insulin was on fourth position with an annual 
expenditure just short of one million Indian Rupees. The top 10 include 3 anti-
virals and 2 anti-bacterial preparations showing the high consumption and costs 
of the anti-microbial agents. The least unit cost in the A category was Rs. 0.18 for 
ferrous sulphate – folic acid combination. CONCLUSIONS: Antimicrobilas 
consumed major resources of the charity hospital. Control on antimicrobial 
prescription with updated protocols and adoption of government free supply of 
anti-retroviral drugs will substantially reduce the hospital budget on medicines.  
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OBJECTIVES: Uninsurance has been shown to reduce health care utilization, but 
this effect may vary by uninsurance duration. Moreover, some argue that 
attitudes toward health insurance and medical care confound the association 
between uninsurance and utilization, but are rarely examined because they are 
often unobserved. This study examined the effects of uninsurance duration on 
prescription medication (RX) and emergency department (ED) utilization after 
adjusting for individuals’ attitudes towards health care and health insurance in 
US nonelderly adults. METHODS: Pooled data from panels 9 to 14 of the MEPS 
longitudinal data files (2004-2010) were used. Uninsured individuals were 
categorized by duration of uninsurance as 1-5, 6-11, 12-23 months and >=2 years 
and were compared to two-year privately and two-year publicly insured 
individuals. Four attitudinal responses were explored, including 
acknowledgement that one is more likely to take risks than the average person 
and beliefs that one is too healthy to need insurance, that insurance is not worth 
the cost, and that one is able to overcome illness without professional help. 
Zero-inflated Poisson and zero-inflated negative binomial models were applied 
using complex survey design correction in STATA 12 to adjust for differences in 
sociodemographic characteristics and health status. Results were reported as 
incidence rate ratios with 95% confidence intervals. RESULTS: Compared to two-
year privately insured, individuals who were uninsured >=6 months used fewer 
RXs, and the reduction increased with uninsurance duration. All uninsured 
categories had more ED visits compared to two-year privately insured with no 
clear trend by duration. Including attitudinal variables had negligible effect on 
estimates of uninsurance. Those disagreeing with the attitudinal responses were 
found to utilize more RX; only those who disagreed with being able to overcome 
illness without help were found to have increased ED utilization. CONCLUSIONS: 
Uninsured had fewer prescription drugs but more ED visits. Attitudes towards 
insurance and medical care did not confound uninsurance effect.  
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OBJECTIVES: To determine the nature and types of medication prescribing errors 
in Egyptian community setting. METHODS: The preparation of this study 
involved a survey of 800 medical prescriptions of different specialties collected 
from outpatients in Egyptian community setting and analyzed to determine the 
nature and types of medication prescribing errors. RESULTS: Out of the 2241 
errors observed, the lack of diagnosis and patient information were noted in 
17.89% and 14.77% respectively making them the top most medication error. This 
was followed by drug-drug interactions (DDIs) were noted in 13.97% of 
prescription, illegible handwriting in 8.66%, lack of signature in 7.89%, treatment 
duration not mentioned in 7.05%, unspecified allergy in 5.44%, inappropriate 
dose in 3.75%, drug without dose in 3.44%, use of abbreviations in 3.03%, 
inappropriate/lack of indication in 2.85%, drugs without administration route in 
2.81%, drugs with the same indication in 2.78%, dose higher than recommended 
in 2.10%, wrong frequency in 1.23%, drugs with wrong/inappropriate route in 
1.22%, confusion with drug name in 0.76%, and inappropriate use of decimal 
points in 0.22% of prescriptions. CONCLUSIONS: 1) Most prescriptions 
investigated were inadequate in terms of legibility, use of abbreviations and 
omitted items, entailing serious risks for patient safety; 2) All prescribing errors 
occurred are preventable; and 3) Electronic prescriptions, computerized 
physician order entry (CPOE), software assisted clinical decision may also 
significantly reduce prescribing errors.  
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OBJECTIVES: Injectable medications are common in the hospital setting and 
susceptible to errors that may harm patients. We conducted a descriptive analysis 
of injectable medication errors reported in the hospital setting in order to inform 
prevention efforts. METHODS: Year 2011 records documenting medication errors 
associated with injectable drugs were extracted from a national medication error 
reporting system representing ~1000 United States hospitals (Quantros Medmarx). 
Injectable medications were defined by administration routes “subcutaneous”, 
“intravenous”, “intramuscular”, or “epidural”. Records identifying inpatient and 
outpatient errors that reached the patient (National Coordinating Council 
Medication Error Reporting and Prevention Categories C-I) were analyzed. For each 
record, staff type (discovered error), physical location, stage within the medication 
use process (prescribing, transcribing, dispensing, administering, monitoring, 
procuring) and error type were analyzed. RESULTS: 5389 records identified 
injectable medication errors (4860 inpatient, 529 outpatient). Although seventeen 
different staff types discovered errors, 75% of records identified a nurse as 
discovering the error. Error locations most frequently reported were nursing units 
(59%), pharmacy (16%), ICU (10%), and emergency department (8%). The distribution 
of errors throughout the medication use process was: administering (57%), 
dispensing (20%), transcribing (12%), prescribing (8%), monitoring (2%) and 
procuring (1%). During administering, errors were most often typed as “omission 
error” (34%), “improper dose/quantity” (20%), “unauthorized/wrong drug” (10%), 
“wrong time” (9%), “wrong administration technique” (9%) and “extra dose” (8%). 
During dispensing (includes pharmacy preparation), errors were most often typed 
as “omission error” (25%), “improper dose/quantity” (20%), “wrong time” (17%) and 
“unauthorized/wrong drug” (10%). CONCLUSIONS: In 2011, the most frequent 
injectable medication errors were related to drug administering in nursing units 
and dose preparation and timing in pharmacy dispensing, with dose accuracy being 
a contributing factor in both locations. Prevention efforts can be targeted on 
medication use processes and hospital locations where errors occur most often.  
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OBJECTIVES: The objective of this study is to project the number of nonelderly 
people who could gain coverage under the Patient Protection and Affordable Care 
Act (PPACA) for the period from 2014 through 2020 in the 13-county Houston-
Galveston area region. METHODS: The 2008 and 2009 American Community 
Survey (ACS) Public Use Microdata file data were used to obtain current county-
level data on the uninsurance rate in the region, weighted by age, income, and 
citizenship status. The impact of PPACA was projected based on estimates of 
growth in the size of targeted populations in each county and the anticipated 
responses of those populations to the major provisions of PPACA. To project 
coverage with PPACA, participation rates (the percent of the eligible population 
likely to enroll in Medicaid or purchase private insurance in an exchange or 
elsewhere) were applied to the projected number of uninsured in applicable 
groups. The participation rates are informed assumptions based on the best 
evidence available from public and private insurance studies currently available 
in the literature. RESULTS: We estimated county level projection in the 12-
county Houston-Galveston region. The projections indicate that, if fully 
implemented, PPACA could cut the uninsurance rate in the region by half, from 
26% in 2010 to 13% in 2020. This change translates into health insurance 
coverage for approximately 2 million additional people, from the current 4.2 
million to a projected 5.9 million. The number of Medicaid enrollees could 
increase by an estimated 600,000 (a 79% increase), although private insurance 
coverage, which could increase by as much as 1 million enrollees (a 30% 
increase), will remain the primary source of coverage for most people. 
CONCLUSIONS: Coverage gains from PPACA will vary considerably by county, 
depending on the age-income-citizenship characteristics of the population, 
current uninsurance rates, and the rate of population growth.  
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OBJECTIVES: To evaluate and synthesize the evidence regarding effective and 
efficient interventions to enhance enrollment of women into health research 
study. METHODS: Comprehensive search done in PubMed, EBSCO, and ProQuest 
databases looking for studies evaluating different recruitment interventions (RI) 
for women participation in clinical trials/observational studies. Studies were 
